Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
AVON ORGANIC TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AVON ORGANIC Mar-23 |
TEVA PHARMA Dec-13 |
AVON ORGANIC/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 7 | 3,481 | - | |
Low | Rs | 2 | 3,024 | - | |
Sales per share (Unadj.) | Rs | 0 | 1,997.6 | - | |
Earnings per share (Unadj.) | Rs | -2.3 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | -0.6 | 286.3 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.24 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | -53.7 | 2,219.0 | - | |
Shares outstanding (eoy) | m | 23.83 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 1.6 | - | |
Avg P/E ratio | x | -1.8 | 26.1 | -7.1% | |
P/CF ratio (eoy) | x | -6.9 | 11.4 | -60.8% | |
Price / Book Value ratio | x | -0.1 | 1.5 | -5.5% | |
Dividend payout | % | 0 | 87.5 | -0.0% | |
Avg Mkt Cap | Rs m | 102 | 2,757,874 | 0.0% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 2 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,690.2 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.5 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 1,693,984 | 0.0% | |
Other income | Rs m | 0 | 0 | - | |
Total revenues | Rs m | 0 | 1,693,984 | 0.0% | |
Gross profit | Rs m | -15 | 463,899 | -0.0% | |
Depreciation | Rs m | 41 | 136,926 | 0.0% | |
Interest | Rs m | 0 | 33,273 | 0.0% | |
Profit before tax | Rs m | -56 | 293,700 | -0.0% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,798 | -0.0% | |
Tax | Rs m | 0 | -3,586 | -0.0% | |
Profit after tax | Rs m | -56 | 105,822 | -0.1% | |
Gross profit margin | % | 0 | 27.4 | - | |
Effective tax rate | % | 0 | -1.2 | 0.0% | |
Net profit margin | % | 0 | 6.2 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 377 | 1,144,111 | 0.0% | |
Current liabilities | Rs m | 1,659 | 997,761 | 0.2% | |
Net working cap to sales | % | 0 | 8.6 | - | |
Current ratio | x | 0.2 | 1.1 | 19.8% | |
Inventory Days | Days | 0 | 91 | - | |
Debtors Days | Days | 0 | 96 | - | |
Net fixed assets | Rs m | 376 | 553,293 | 0.1% | |
Share capital | Rs m | 238 | 4,170 | 5.7% | |
Net worth | Rs m | -1,280 | 1,881,695 | -0.1% | |
Long term debt | Rs m | 327 | 866,172 | 0.0% | |
Total assets | Rs m | 753 | 3,871,297 | 0.0% | |
Interest coverage | x | 0 | 9.8 | - | |
Debt to equity ratio | x | -0.3 | 0.5 | -55.4% | |
Sales to assets ratio | x | 0 | 0.4 | 0.0% | |
Return on assets | % | -7.4 | 3.6 | -205.2% | |
Return on equity | % | 4.3 | 5.6 | 77.2% | |
Return on capital | % | 5.8 | 4.9 | 118.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 9 | 269,933 | 0.0% | |
From Investments | Rs m | NA | -95,648 | -0.0% | |
From Financial Activity | Rs m | -9 | -323,803 | 0.0% | |
Net Cashflow | Rs m | 0 | -149,518 | -0.0% |
Compare AVON ORGANIC With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare AVON ORGANIC With: VALIANT LABORATORIES LTD. SAROJA PHARMA INDUSTRIES INDIA LTD. MEDPLUS HEALTH SERVICES S.S.ORGANICS ASTRAZENECA PHARMA
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.